FDA scientists appear to offer major endorsement of Biogen’s controversial Alzheimer’s treatment – STAT

The future of aducanumab, Biogen’s treatment for Alzheimer’s, appears brighter after reviewers at the FDA indicated they believed the drug was sufficiently safe and effective.

Full Story